Fashionable drugs is dealing with a major pricing disaster. Whereas breakthrough gene therapies supply potential cures for uncommon genetic illnesses and aggressive cancers, the costs typically exceed £370,000 and even £1 million per affected person, making them a logistical nightmare for healthcare methods. The bottleneck often isn’t the science itself, however the advanced, costly manufacturing... Read More








:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)


Recent Comments